# Genetic testing for inherited heart conditions

Intervention · id `cardio:genetic-testing-for-inherited-heart-conditions` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

Genetic testing looks for changes in a person's DNA. A US government patient page says such changes, sometimes called variants or mutations, often have no effect, but sometimes even a small change can cause disease. The page says the test is often done on a blood or cheek swab sample, that most testing is done through a health care provider, and that the physical risks are small but there can be emotional, social or financial drawbacks. A review of inherited heart rhythm conditions tabulates the genes linked to long QT syndrome, CPVT, Brugada syndrome and ARVC.

## Technical summary

MeSH descriptor D005820 (Genetic Testing) is a general heading, not specific to the heart, so the code is stored as broad; its scope note covers detection of a mutation, genotype, karyotype or specific alleles linked to inherited disease or predisposition. The test descriptions come from the MedlinePlus genetic testing summary (page last updated August 13, 2025). A 2023 review (CC BY 3.0) tabulates the major genes for long QT syndrome, CPVT, Brugada syndrome and ARVC, and a 2018 review (CC BY 4.0) discusses testing for long QT syndrome and CPVT. One 2022 audit (CC BY 4.0) of a single specialised clinic in Sydney, Australia, reports that, of 1,697 referred probands, 888 met its inclusion criteria and that testing in those 888 found likely pathogenic or pathogenic variants in 330 (37%) and variants of uncertain significance in 73 (8%); that is one clinic's referred patients, not a rate for any other group. This page does not say who should be tested, what a result means for a relative, or how results change care. It carries no clinical review.

## Connected pages

- Files under this front: Diagnostics and imaging (`cardio:front-diagnostics-and-imaging`)
- Related to: Arrhythmogenic right ventricular cardiomyopathy (`cardio:arrhythmogenic-right-ventricular-cardiomyopathy`)
- Related to: Brugada syndrome (`cardio:brugada-syndrome`)
- Related to: Catecholaminergic polymorphic ventricular tachycardia (`cardio:catecholaminergic-polymorphic-ventricular-tachycardia`)
- Related to: Long QT syndrome (`cardio:long-qt-syndrome`)

## Provenance

Content hash: df699d5ef2280b186ee330bb774a7eef3299cc1fa01c65269195597c47abc2f2
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
